Psychedelics Psychedelic retreats on the rise for executives seeking mental expansion Insights into the world of psychedelic business retreats Zartasha MushtaqMarch 14, 2024
Psychedelics Controversial figure Dana Larsen gets his psychedelics business license back He had it suspended last May and his stores were raided by police in November, but it appears his perseverance has paid off Rowan DunneMarch 7, 2024
Psychedelics Archaeologists find evidence of ceremonial psychedelic use at ancient biblical site They found several plants known to be connected to the worship of female Greek deities Rowan DunneMarch 5, 2024
Psychedelics Alaska senate considers psychedelics task force proposal Legislation anticipates federal legalization, establishes the Alaska Mental Health and Psychedelics Medicine Task Force Zartasha MushtaqFebruary 7, 2024
Psychedelics Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne Mind Medicine Australia legally dosed the first patients outside of clinical trials in over 50 years last month Rowan DunneFebruary 1, 2024
Psychedelics Filament Health ships psilocybin drug to Australia, first country legally prescribing psychedelics The shipment was received by the medical cannabis company Little Green Pharma and its psychedelics subsidiary Rowan DunneJanuary 17, 2024
Psychedelics California shifts focus to psychedelic therapy after setback on ‘magic mushrooms’ Lawmakers to explore alternate routes amid challenges in broader decriminalization of psychedelics Zartasha MushtaqJanuary 16, 2024
Psychedelics MAPS subsidiary raises over US$100M to support MDMA regulation The funding was led by the non-profit Helena, a diverse organization that aims to solve global problems Rowan DunneJanuary 5, 2024
Psychedelics Ron ‘Tater Salad’ White appointed to Rythmia ayahuasca centre’s leadership roster White had been struggling with issues related to excessive alcohol consumption prior to visiting the Costa Rica facility Rowan DunneDecember 15, 2023
Psychedelics Terran Biosciences obtains U.S. patent approval for catalogue of novel psychedelics They include two new forms of psilocybin, orally active DMT and 5-MeO-DMT, and an ibogaine derivative Rowan DunneDecember 11, 2023